e-learning
resources
London 2016
Sunday, 04.09.2016
What's new in biomarker analysis?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups
Matthew Gueble (Durham, United States of America), Matthew Gueble, Carole Holm, Nicole Grant, Lois Ravage-Mass, Terri-Dawn Levesh, Jean Estrom, Eleni Kapagiannidou, Qing Liu, Peggy O’Connor, Jose Gomez-Villalobos, Lauren Cohn, Geoffrey Chupp
Source:
International Congress 2016 – What's new in biomarker analysis?
Session:
What's new in biomarker analysis?
Session type:
Thematic Poster
Number:
908
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Matthew Gueble (Durham, United States of America), Matthew Gueble, Carole Holm, Nicole Grant, Lois Ravage-Mass, Terri-Dawn Levesh, Jean Estrom, Eleni Kapagiannidou, Qing Liu, Peggy O’Connor, Jose Gomez-Villalobos, Lauren Cohn, Geoffrey Chupp. Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups. Eur Respir J 2016; 48: Suppl. 60, 908
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Correlation of inflammatory markers of disease with sputum neutrophilia in severe asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
Distribution of sputum cellular phenotype in a large asthma cohort. Predicting factors for eosinophilic vs neutrophilic inflammation
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
LATE-BREAKING ABSTRACT: Sputum transcriptome analysis yields eosinophilic and non-eosinophilic inflammatory mechanisms in UBIOPRED asthma cohort
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Aspirin hypersensitive and aspirin-tolerant eosinophilic asthma share common patern of inflammatory cells influx and lipid mediators in airways
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic
Source: Annual Congress 2013 –Asthma
Year: 2013
Airway basophils are increased and correlated with eosinophilic inflammtaion in asthma and COPD
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
The role of IL-13, IL-4Rα cytokine gene variants in atopic and non-atopic asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Pathology, inflammation and cytokines of severe asthma
Source: Eur Respir Mon 2011; 51: 97-106
Year: 2011
Bronchial hyperactivity in perimenstrual asthma is higher than in non-PMA asthmatics and correlates with sputum levels of eotaxin and IL-4
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Modulation of inflammation by benralizumab in eosinophilic airway disease
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept